Cargando…
Recovery of Recombinant Canine Distemper Virus That Expresses CPV-2a VP2: Uncovering the Mutation Profile of Recombinant Undergoing 50 Serial Passages In Vitro
Canine distemper and canine parvoviral enteritis are infections caused by the canine distemper virus (CDV) and canine parvovirus type 2 (CPV-2), respectively. They are two common infectious diseases that cause high morbidity and mortality in affected dogs. Combination vaccines have been broadly used...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795682/ https://www.ncbi.nlm.nih.gov/pubmed/35096636 http://dx.doi.org/10.3389/fcimb.2021.770576 |
_version_ | 1784641125693259776 |
---|---|
author | Liu, Fuxiao Lin, Jiahui Wang, Qianqian Zhang, Youming Shan, Hu |
author_facet | Liu, Fuxiao Lin, Jiahui Wang, Qianqian Zhang, Youming Shan, Hu |
author_sort | Liu, Fuxiao |
collection | PubMed |
description | Canine distemper and canine parvoviral enteritis are infections caused by the canine distemper virus (CDV) and canine parvovirus type 2 (CPV-2), respectively. They are two common infectious diseases that cause high morbidity and mortality in affected dogs. Combination vaccines have been broadly used to protect dogs from infections of CDV, CPV-2, and other viruses. VP2 is the most abundant protein of the CPV-2 capsid. It elicits potent immunity in animals and, therefore, is widely used for designing subunit antigen-based vaccines. In this study, we rescued a recombinant CDV (QN vaccine strain) using reverse genetics. The recombinant CDV (rCDV-VP2) was demonstrated to express stably the VP2 in cells for at least 33 serial passages in vitro. Unfortunately, a nonsense mutation was initially identified in the VP2 open reading frame (ORF) at passage-34 (P34) and gradually became predominant in rCDV-VP2 quasispecies with passaging. Neither test strip detection nor indirect immunofluorescence assay demonstrated the expression of the VP2 at P50. The P50 rCDV-VP2 was subjected to next-generation sequencing, which totally identified 17 single-nucleotide variations (SNVs), consisting of 11 transitions and 6 transversions. Out of the 17 SNVs, 1 and 9 were identified as nonsense and missense mutations, respectively. Since the nonsense mutation arose in the VP2 ORF as early as P34, an earlier rCDV-VP2 progeny should be selected for the vaccination of animals in future experiments. |
format | Online Article Text |
id | pubmed-8795682 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87956822022-01-29 Recovery of Recombinant Canine Distemper Virus That Expresses CPV-2a VP2: Uncovering the Mutation Profile of Recombinant Undergoing 50 Serial Passages In Vitro Liu, Fuxiao Lin, Jiahui Wang, Qianqian Zhang, Youming Shan, Hu Front Cell Infect Microbiol Cellular and Infection Microbiology Canine distemper and canine parvoviral enteritis are infections caused by the canine distemper virus (CDV) and canine parvovirus type 2 (CPV-2), respectively. They are two common infectious diseases that cause high morbidity and mortality in affected dogs. Combination vaccines have been broadly used to protect dogs from infections of CDV, CPV-2, and other viruses. VP2 is the most abundant protein of the CPV-2 capsid. It elicits potent immunity in animals and, therefore, is widely used for designing subunit antigen-based vaccines. In this study, we rescued a recombinant CDV (QN vaccine strain) using reverse genetics. The recombinant CDV (rCDV-VP2) was demonstrated to express stably the VP2 in cells for at least 33 serial passages in vitro. Unfortunately, a nonsense mutation was initially identified in the VP2 open reading frame (ORF) at passage-34 (P34) and gradually became predominant in rCDV-VP2 quasispecies with passaging. Neither test strip detection nor indirect immunofluorescence assay demonstrated the expression of the VP2 at P50. The P50 rCDV-VP2 was subjected to next-generation sequencing, which totally identified 17 single-nucleotide variations (SNVs), consisting of 11 transitions and 6 transversions. Out of the 17 SNVs, 1 and 9 were identified as nonsense and missense mutations, respectively. Since the nonsense mutation arose in the VP2 ORF as early as P34, an earlier rCDV-VP2 progeny should be selected for the vaccination of animals in future experiments. Frontiers Media S.A. 2022-01-14 /pmc/articles/PMC8795682/ /pubmed/35096636 http://dx.doi.org/10.3389/fcimb.2021.770576 Text en Copyright © 2022 Liu, Lin, Wang, Zhang and Shan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Liu, Fuxiao Lin, Jiahui Wang, Qianqian Zhang, Youming Shan, Hu Recovery of Recombinant Canine Distemper Virus That Expresses CPV-2a VP2: Uncovering the Mutation Profile of Recombinant Undergoing 50 Serial Passages In Vitro |
title | Recovery of Recombinant Canine Distemper Virus That Expresses CPV-2a VP2: Uncovering the Mutation Profile of Recombinant Undergoing 50 Serial Passages In Vitro
|
title_full | Recovery of Recombinant Canine Distemper Virus That Expresses CPV-2a VP2: Uncovering the Mutation Profile of Recombinant Undergoing 50 Serial Passages In Vitro
|
title_fullStr | Recovery of Recombinant Canine Distemper Virus That Expresses CPV-2a VP2: Uncovering the Mutation Profile of Recombinant Undergoing 50 Serial Passages In Vitro
|
title_full_unstemmed | Recovery of Recombinant Canine Distemper Virus That Expresses CPV-2a VP2: Uncovering the Mutation Profile of Recombinant Undergoing 50 Serial Passages In Vitro
|
title_short | Recovery of Recombinant Canine Distemper Virus That Expresses CPV-2a VP2: Uncovering the Mutation Profile of Recombinant Undergoing 50 Serial Passages In Vitro
|
title_sort | recovery of recombinant canine distemper virus that expresses cpv-2a vp2: uncovering the mutation profile of recombinant undergoing 50 serial passages in vitro |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795682/ https://www.ncbi.nlm.nih.gov/pubmed/35096636 http://dx.doi.org/10.3389/fcimb.2021.770576 |
work_keys_str_mv | AT liufuxiao recoveryofrecombinantcaninedistempervirusthatexpressescpv2avp2uncoveringthemutationprofileofrecombinantundergoing50serialpassagesinvitro AT linjiahui recoveryofrecombinantcaninedistempervirusthatexpressescpv2avp2uncoveringthemutationprofileofrecombinantundergoing50serialpassagesinvitro AT wangqianqian recoveryofrecombinantcaninedistempervirusthatexpressescpv2avp2uncoveringthemutationprofileofrecombinantundergoing50serialpassagesinvitro AT zhangyouming recoveryofrecombinantcaninedistempervirusthatexpressescpv2avp2uncoveringthemutationprofileofrecombinantundergoing50serialpassagesinvitro AT shanhu recoveryofrecombinantcaninedistempervirusthatexpressescpv2avp2uncoveringthemutationprofileofrecombinantundergoing50serialpassagesinvitro |